OIM
ABEO icon

Oracle Investment Management’s Abeona Therapeutics ABEO Stock Holding History

Oracle Investment Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-53,958
Closed -$4.24M – 28
2015
Q1 		$4.24M Sell
53,958
-53,518
-50% -$4.31M 0.54% 23
2014
Q4 		$9.27M Buy
+107,476
New +$9.64M 1.22% 20

Other funds holding ABEO

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CT
Cambridge Trust Cambridge, Massachusetts $2.64B AUM 28.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Oracle Investment Management's ABEO Position: Q2 2015 in Review

Oracle Investment Management sold out of Abeona Therapeutics (ABEO) in Q2 2015, closing a stake of 53,958 shares — an estimated $4.24M sold.

Oracle Investment Management first reported a position in ABEO in Q4 2014 and held it in 2 quarters. The position peaked at $9.27M in Q4 2014. 42 funds tracked by Wall St. Rank hold ABEO as of Q2 2015.

  • Oracle Investment Management reported no remaining Abeona Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Oracle Investment Management sold 53,958 Abeona Therapeutics shares in Q2 2015, an estimated $4.24M.
  • Oracle Investment Management first reported a position in Abeona Therapeutics in Q4 2014 and held it in 2 quarters.
  • Oracle Investment Management's Abeona Therapeutics position peaked at $9.27M in Q4 2014.
  • 42 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2015.

Based on Oracle Investment Management's 13F filing for Q2 2015, filed 14 Aug 2015.